http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1b3f1cf46fe37ab153b795f1a9a28e3a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Saad |
| name | Fred Saad |
| given-name | Fred |
| organization-name | Division of Urology Department of Surgery Centre Hospitalier de l’Université de Montréal (CHUM) Montréal Quebec Canada Genitourinary Oncology, Centre Hospitalier de l’Université de Montréal, University of Montreal, Montréal, QC, Canada aCancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada;; gDivision of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada; and Department of Surgery, University of Montreal, Montreal, Quebec, Canada 4Urology, Centre Hospitalier Universitaire de Montreal, and Centre Hospitalier de l'Université de Montréal University of Montreal Montreal Quebec Canada Department of Surgery/Urology, University of Montreal Hospital Center (CHUM), Montreal, Canada c Urology-Oncology, CRCHUM University of Montreal, Montreal, Quebec, Canada; 8Department of Surgery, University of Montreal Hospital Centers, Montreal, Quebec, Canada. University of Montreal Hospital Center (CHUM), Montreal Cancer Institute/CRCHUM, Montreal, Quebec University of Montreal Health Center, Montreal, Quebec Canada. Division of Urology, Department of Surgery, Université de Montréal, Montreal, QC, Canada. Centre Hospitalier de l'Université de Montréal, Department of Urology, Montreal, QC, Canada From the Department of Surgery/Urology, Centre Hospitalier de l’Université de Montréal, University of Montreal, Montreal; Department of Rheumatology, University of Laval, Sainte-Foy, Quebec; Department of Medicine, St. Joseph's Healthcare, McMaster University, Hamilton; Kaleidoscope Strategic Inc; Division of Endocrinology and Metabolism, Department of Medicine, St. Michael's Hospital; Department of Medicine, Sunnybrook Odette Cancer Centre, University of Toronto, Toronto, Ontario; British Columbia... Cancer Prognostics and Health Outcomes Unit; University of Montreal Health Center; Montreal Canada; Department of Urology; University of Montreal Health Center; Montreal Canada Centre Hospitalier de l’Université de Montréal/CRCHUM, Montréal, Canada Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada 6Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montreal, Quebec, Canada; and Division of Urology & Urologic Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, QC, Canada Division of Urology, Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montréal Health Center Montréal Québec Canada Glenn Heller, Martin Fleisher, and Howard I. Scher, Memorial Sloan Kettering Cancer Center; Howard I. Scher, Weill Cornell Medical College, New York, NY; Robert McCormack, Janssen Research & Development, Raritan, NJ; Thian Kheoh and Arturo Molina, Janssen Research & Development, Los Angeles; Dana T. Aftab, Exelixis, South San Francisco; Mohammad Hirmand, Medivation, San Francisco, CA; Matthew R. Smith, Massachusetts General Hospital, Boston; Ana Limon, Takeda Oncology, Cambridge, MA; Robert Dreicer,... University of Montreal Hospital Centre, Montreal, PQ, Canada. fred.saad.chum@ssss.gouv.qc.ca 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal and Institut du Cancer de Montréal,; 5Département d'Urologie, Université de Montréal, Montréal, Québec, Canada Matthew R. Smith, Massachusetts General Hospital Cancer Center; Benjamin Z. Leder, Massachusetts General Hospital Endocrine Unit, Boston, MA; Fred Saad, Centre Hospitalier de l'Université de Montréal, Montreal, Quebec; Blair Egerdie, Urology Associates Urologic Medical Research, Kitchener, Ontario, Canada; Paul R. Sieber, Urologic Associates, Lancaster, PA; Teuvo L.J. Tammela, Tampere University Hospital, Tampere, Finland; and Chunlei Ke and Carsten Goessl, Amgen, Thousand Oaks, CA. From the Robert H. Lurie Comprehensive Cancer Center, Feinberg School of Medicine, Northwestern University, Chicago (M.H.), and Astellas Pharma, Northbrook (D.P., A.K.) — both in Illinois; Institut Gustave Roussy, University of Paris Sud, Villejuif, France (K.F.); the University of Montreal Hospital Center, Montreal (F.S.); Herlev Hospital, Herlev, Denmark (P.R.); Carolina Urologic Research Center, Myrtle Beach, SC (N.S.); State University of Campinas (Unicamp), Campinas, Brazil (U.F.); Kiev City... Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada. fred.saad@ssss.gouv.qc.ca 1Département de chirurgie (urologie), Centre Hospitalier de l’Université de Montreal–Montréal, Montreal, Quebec, Canada;; 2Centre de recherche du Centre Hospitalier de l’Université de Montreal and Institut du Cancer de Montréal, Montreal, Quebec, Canada; 5Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada Centre Hospitalier de L'Universite de Montreal, Montreal, QC, Canada. Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) Institut du cancer de Montréal Montréal Québec Canada; Department of Urology Centre Hospitalier de l'Université de Montréal (CHUM) Québec Canada Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, 1560 Rue Sherbrooke East, Quebec, H2L 4M1, Montréal, Canada. fred.saad@sss.gouv.qc.ca Department of Surgery Université de Montréal Montreal QC Canada Prostate Centre at Vancouver General Hospital, BC Cancer Agency, Vancouver Centre and the Canadian Uro-Oncology Group, Vancouver, British Columbia, the London Health Sciences Centre, London, Sunnybrook Regional Cancer Centre and Princess Margaret Hospital, Toronto, Ontario, University of Montreal, Montreal, and the Tom Baker Cancer Centre, Calgary, Alberta, Canada Centre Hospitalier de l’Université de Montréal, Department of Surgery/Urologic Oncology, 1560 Rue Sherbrooke East, Montréal, PQ H2L 4M1 Québec, Canada. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center , Montreal , Canada; Department of Urology, University of Montreal Health Center , Montreal , Canada Department of Urology, University of Montreal, Montreal, Canada 1Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada; University of Montreal Hospital Center, Montreal, Quebec, Canada Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Stephane Oudard, Université Paris Descartes, Paris, France; Robert Jones, Institute of Cancer Sciences, University of Glasgow, Glasgow; Johann De Bono, The Institute of Cancer Research, London, United Kingdom; Eleni Efstathiou, University of Athens Medical School, Athens; George Fountzilas, Aristotle University of Thessaloniki School of Medicine, Thessaloniki, Greece; Fred Saad, University of Montreal Hospital Center, Montreal,... Professor and Chair, Division of Urology, University of Montreal Hospital Center and CRCHUM, CHUM, 1560 Sherbrooke East, Montreal Quebec H2L 4M1, Canada University of Montréal, Montréal, Québec, Canada. Department of Surgery, Centre Hospitalier de l'Université de Montréal (CHUM), Montreal, Canada M. Dror Michaelson, Massachusetts General Hospital Cancer Center, Boston, MA; Stephane Oudard, George Pompidou European Hospital, Rene Descartes University, Paris; Nadine Houede, Institut Bergonie, Bordeaux; Tristan Maurina, CHU de Besançon, Hôpital Jean Minjoz, Besançon, France; Yen-Chuan Ou, Taichung Veterans General Hospital, Taichung, Taiwan; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Rigshospitalet, Copenhagen, Denmark; Fred Saad, University of Montreal, Montreal, Canada; Peter Ostler,... Centre Hospitalier de I’Université de Montréal, Montreal, Canada University of Montreal, Montreal, QC, Canada. Centre Hospitalier de l’Université de Montréal, Montréal, Québec, Canada Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Canada.; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, Canada. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Quebec, Canada 1Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada;; 10Division of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada; and Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montreal Health Center Montreal Quebec Canada Centre Hospitalier de l’Université de Montréal, Montreal Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada. 11Department of Surgery, University of Montréal, Montréal, Québec, Canada. From the Institute of Cancer Research and Royal Marsden Hospital, London (J. de Bono), and AstraZeneca, Translational Medicine, Cambridge (C.A.A.) — all in the United Kingdom; Vall d’Hebron Institute of Oncology and Vall d’Hebron University Hospital, Barcelona (J.M.), the Spanish National Cancer Research Center, Madrid (D.O.), and Hospitales Universitarios Virgen de la Victoria y Regional de Málaga, Malaga (D.O.) — all in Spain; Institut Gustave Roussy, University of Paris Sud, Villejuif (K.F.), and the... University of Montreal Hospital Research Centre (CRCHUM) Montreal Quebec Canada Cancer Prognostics and Health Outcomes Unit University of Montreal Health Center Montreal Quebec Canada Department of Surgery Université de Montréal Montreal Quebec Canada Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montréal Health Center Montréal QC Canada Division of Urology, Cancer Prognostics and Health Outcomes Unit University of Montréal Health Center Montréal, Québec Canada Department of Urology, Centre Hospitalier de l'Université de Montréal/CRCHUM, Montreal, QC, Canada From the Massachusetts General Hospital, Boston, MA; University of California at Los Angeles, Los Angeles; University of California at San Francisco, San Francisco; Western Clinical Research, Torrance, CA; University of Montreal, Montreal, Canada; University of Maryland, Baltimore, MD; S Florida Medical Research, Aventura, FL; Christchurch Hospital, Christchurch, New Zealand; Peter MacCallum Cancer Institute, Melbourne, Australia; Free University of Brussels, Brussels, Belgium; Novartis Oncology, East... Centre Hospitalier de l'Université de Montréal/CRCHUM, Montreal, Canada. From the British Columbia Cancer Agency–Vancouver Centre; Vancouver Prostate Centre, Vancouver, British Columbia; Juravinski Cancer Centre, Hamilton; National Cancer Institute of Canada Clinical Trials Group, Kingston; Princess Margaret Hospital, Toronto, Ontario; Tom Baker Cancer Centre, Calgary; Cross Cancer Institute, Edmonton, Alberta; University of Montreal, Montreal, Quebec, Canada; and University of Washington, Seattle, WA. Department of Surgery, Hôpital Notre-Dame, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, QC, Canada H2L 4M1; 5University of Montreal, Montreal, Quebec, Canada. Department of Urology, Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada CHUM-Pavillon Notre-Dame and Institut du cancer de Montréal. Cancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada.; Division of Urology, University of Montreal Hospital Center (CHUM), Montreal, Quebec, Canada. Division of Urology and Urologic Oncology, Centre Hospitalier de Université de Montréal, University of Montreal, Montreal, QC, Canada. Authors' Affiliations: 1Goodman Cancer Research Center, 2Department of Biochemistry, McGill University; 3Research Center of the Université de Montréal Hospital Center (CRCHUM), Institut du cancer de Montréal, and Faculty of Medicine, Departments of 4Pathology, 5Medicine, and 6Urology, CHUM, Université de Montréal, Montréal, Québec, Canada; and 7Shigei Medical Research Institute, Yamada, Okayama, Japan; Authors' Affiliations: 1Goodman Cancer Research Center, 2Department of Biochemistry, McGill University; 3Research Center of the Université de Montréal Hospital Center (CRCHUM), Institut du cancer de Montréal, and Faculty of Medicine, Departments of 4Pathology, 5Medicine, and 6Urology, CHUM, Université de Montréal, Montréal, Québec, Canada; and 7Shigei Medical Research Institute, Yamada, Okayama, Japan Centre de recherche du Centre hospitalier de l’Université de Montréal, Montreal, Quebec Tomasz M. Beer, Oregon Health and Science University, Portland, OR; Eugene D. Kwon, Mayo Clinic, Rochester, MN; Charles G. Drake, Johns Hopkins University, Baltimore, MD; Karim Fizazi, University of Paris-Sud, Villejuif; Gwenaelle Gravis, Institut Paoli-Calmettes, Marseille, France; Christopher Logothetis, University of Texas MD Anderson Cancer Center, Houston, TX; Vinod Ganju, Monash University, Melbourne, Victoria; Siobhan S. Ng, St John of God Hospital, Subiaco, Western Australia; Francis X. Parnis,... Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada. Associate Professor of Surgery/Urology Université de Montréal Montréal, Québec. 5Centre Hospitalier de l'Université de Montréal, Faculty of Medicine, Université de Montréal, Québec, Canada. Centre Hospitalier de l’Université de Montréal, Université de Montréal, Montreal, Québec, Canada Glenn Heller, Memorial Sloan Kettering Cancer Center, New York, NY; Robert McCormack and Thian Kheoh, Janssen Research & Development, Raritan, NJ; Arturo Molina, Janssen Research & Development, Los Angeles, CA; Matthew R. Smith, Massachusetts General Hospital, Boston, MA; Robert Dreicer, University of Virginia Medical School, Charlottesville, VA; Fred Saad, University of Montreal, Montreal, Quebec, Canada; Ronald de Wit, Erasmus Medical Center, Rotterdam, Netherlands; Dana T. Aftab, Exelixis, South San... Stéphane Oudard, Georges Pompidou European Hospital, Rene Descartes University; Mustapha Chadjaa; Sanofi, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif; Antoine Thiery-Vuillemin, Centre Hospitalier Universitaire Minjoz Besançon, Besançon, France; Lisa Sengeløv, Herlev Hospital, Herlev; Gedske Daugaard, Copenhagen University Hospital, Rigshospitalet, Copenhagen; Steinbjørn Hansen, Odense University Hospital, Odense, Denmark; Fred Saad, Centre Hospitalier de l’Université... Cancer Prognostics and Health Outcomes Unit University of Montreal Health Center Montreal Québec Canada; Division of Urology University of Montreal Hospital Center (CHUM) Montreal Québec Canada From the Cancer Prognostics and Health Outcomes Unit; Department of Urology, University of Montreal, Montreal, Quebec, Canada; Department of Urology; Martini Clinic, Prostate Cancer Center, University Medical Centre Eppendorf, Hamburg, Germany; Department of Urology, Vita-Salute University, Milan, Italy; and the Department of Urology, University of Texas Southwestern Medical Center, Dallas, TX Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montréal Health Center Montréal Québec Canada CHUM–-Pavillon R, Montreal, QC, Canada. Cancer Prognostics and Health Outcomes Unit, University of Montreal Hospital Center, Montreal, Quebec, Canada; Division of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada Uro-Oncology Clinic, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. fred.saad@ssss.gouv.qc.ca Authors' Affiliations: Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Institut du Cancer de Montréal, and the Department of Surgery/Urology, CHUM, University of Montréal, Montréal, Québec, Canada Centre Hospitalier de l’Université de Montréal, University of Montreal, Montreal, Quebec, Canada Department of Urology, University of Montreal Hospital Center, Montreal, QC, Canada Department of Urology , University of Montreal Health Center , Montreal , Canada Division of Urology, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada. Matthew R. Smith and Philip Saylor, Massachusetts General Hospital Cancer Center, Boston, MA; Susan Halabi and Ben Sanford, Alliance Statistics and Data Center, Duke University Medical Center, Durham, NC; Charles J. Ryan and Eric J. Small, University of California at San Francisco, San Francisco, CA; Walter Stadler, University of Chicago; Nirmala Bhoopalam, Loyola University of Chicago, Chicago, IL; Arif Hussain, University of Maryland, Baltimore, MD; Nicholas Vogelzang, Nevada Cancer Research Foundation... Urology, Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada University of Montreal Hospital Center , 900 Rue St. Denis, Montreal, Quebec, H2X 0A9, Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM) Montreal QC Canada; Division of Urology Centre Hospitalier de l’Université de Montréal Montreal QC Canada Fred Saad, Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montreal, Quebec, Canada Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada. University of Montreal Hospital Centre, Pavillon R 900, Rue St-Denis, Montreal, Quebec H2X 0A9, Canada aCancer Prognostics and Health Outcomes Unit, University of Montreal Health Center, Montreal, Quebec, Canada;; iDivision of Urology, University of Montreal Hospital Center, Montreal, Quebec, Canada. University of Montreal Montreal QC Canada Centre Hospitalier de l’Université de Montréal, University of Montreal , Montreal, Quebec , Canada 3Department of Urology, University of Montreal, Montreal, Canada; University of Montréal Hospital Center, Montréal, Québec, H2L 4M1, Canada Emmanuel S. Antonarakis and Mario A. Eisenberger, The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD; Scott T. Tagawa, Giuseppe Galletti, Daniel Worroll, Karla Ballman, Ada Gjyrezi, Shinsuke Tasaki, Luigi Portella, Yang Bai, Brian J. Kirby, David M. Nanus, and Paraskevi Giannakakou, Weill Cornell Medicine/Meyer Cancer Center; Che-Kai Tsao, Mount Sinai Medical Center, New York; Timothy B. Lannin, Shalu Suri, Conor N. Gruber, Erica D. Pratt, and Brian J. Kirby, Cornell University... Département d'Urologie du Centre Hospitalier Universitaire de Montréal (CHUM) et Institut du Cancer de Montréal / CRCHUM, Montreal, QC, Canada F Saad, Urology, Centre Hospitalier de L'Universite de Montreal, Montreal, Canada University of Montreal Hospital Center, Montreal, Canada Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Québec, Canada Cancer Prognostics and Health Outcomes Unit University of Montreal Health Center Montreal QC Canada CRCUM‐Université de Montréal Montréal Quebec Centre Hospitalier de l’Universite de Montreal, Montreal University of Montreal Hospital Centre Montreal Quebec Canada 5Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada. 4Department of GU Oncology, University of Montreal Hospital Centre (CHUM), Montreal, Canada. Department of Surgery, CHUM, Université de Montréal, Montréal, Québec, Canada Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, QC, Canada. fred.saad@umontreal.ca Urologic Oncology, Centre Hospitalier de l'Université de Montréal, Montreal, Québec, Canada. Centre Hospitalier de L’université de Montréal, Université de Montréal, Montréal, Québec, Canada. Ethan Basch, Ronald C. Chen, and Stacie B. Dusetzina, University of North Carolina, Chapel Hill; Derek Raghavan, Carolinas Health Care/Levine Cancer Institute, Charlotte, NC; D. Andrew Loblaw, Odette Cancer Centre, Sunnybrook Health Sciences Centre; Ted Wootton, Patient Representatives, Toronto; Sebastian Hotte and Cindy Walker-Dilks, McMaster University; Cindy Walker-Dilks, Cancer Care Ontario, Hamilton; Eric Winquist, London Health Sciences Centre, London, Ontario; Fred Saad, University of Montreal,... Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montréal Health Center, Montréal, Québec, Canada Department of Urology, University of Montreal, Montreal, Quebec, Canada Authors' Affiliations: 1Royal Marsden NHS Foundation Trust and The Institute of Cancer Research UK, Sutton; 2Institut Català d'Oncologia, L'Hospitalet, Barcelona; 3University of Surrey, Surrey, United Kingdom; 4Yale University Cancer Center, New Haven; 5Centre Hospitalier de l'Universite de Montreal, Montreal; 6A Coruña University Hospital, A Coruña, Spain; 7Kantonsspital St. Gallen, St. Gallen, Switzerland; 8Fox Chase Cancer Center, Philadelphia, Pennsylvania; 9Pfizer Inc, Groton, Connecticut; and 10Lady Davis Institute for Medical Research, Jewish General Hospital and McGill University, Montreal, Quebec, Canada Department of Surgery, Université de Montréal, Montreal, Quebec, Canada 2Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada; Centre Hospitalier de l'Université de Montréal, Montréal, Quebec, Canada 1Centre de recherche du Centre hospitalier de l'Université de Montréal (CRCHUM) et Institut du cancer de Montréal, Montréal, Quebec, Canada.; 4Department of Surgery, Université de Montréal, Montreal, Quebec, Canada. Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, Canada Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec, Canada Centre de Recherche du Centre Hospitalier de l’Université de Montréal (CRCHUM)/Institut du Cancer de Montréal, Montreal, Canada; Department of Surgery, Hôpital Saint Luc (CHUM), Montreal, Canada; Department of Surgery, Université de Montréal, Montreal, Canada University of Montreal, CHUM, Hôpital Notre-Dame, Montreal, Quebec, Canada. Department of Urology, Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montréal Health Center Montréal Québec Canada Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, QC, Canada. Electronic address: fred.saad@umontreal.ca. Department of Urology, University of Montreal (CHUM), Montreal, Quebec, Canada. Department of Surgery, Université de Montréal, Centre Hospitalier de l’Université de Montréal (CHUM), Montréal, Canada and Institut du Cancer de Montréal, 1560 Sherbrooke Est, Montréal, Quebéc H2L 2W5, Canada. 1Centre de recherche du Centre hospitalier de l'Université de Montréal and Institut du cancer de Montréal;; 4Département d'urologie, Université de Montréal, Montreal, Quebec, Canada; and Division of Urology, University of Montreal Health Center, Montreal, Quebec, Canada Cancer Prognostics and Health Outcomes Unit, Department of Urology University of Montréal Health Center Montréal Canada Institut du Cancer de Montréal and Centre de Recherche du Centre hospitalier de l, ‘Université de Montréal, Montréal, Québec H2X 0A9, Canada; Department of Surgery, Université de Montréal, Montréal, Québec H2X 0A9, Canada Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal Quebec Canada 7Department of Surgery, University of Montréal, Montréal, Québec, Canada. From the Cancer Prognostics and Health Outcomes Unit, University of Montreal, Montreal, Quebec; and Department of Urology, Mount Sinai and Princess Margaret Hospitals, University of Toronto, Toronto, Ontario, Canada; Department of Urology, University Medical Centre Eppendorf, Hamburg, Germany; and the Department of Urology, University of Texas Southwestern Medical Centre, Dallas, TX Centre Hospitalier de l'Université de Montréal and CRCHUM Montreal Quebec Canada From the Pediatric Urology and Nuclear Medicine Services, Hôpital Sainte-Justine, Université de Montreal, Montreal, Quebec, Canada Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montréal Health Center Montréal, Québec Canada Cancer Prognostics and Health Outcomes Unit University of Montreal Health Center Montreal Canada; Division of Urology University of Montreal Hospital Center (CHUM) Montreal Quebec Canada 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal/Institut du cancer de Montréal;; 3Département de Chirurgie de l'Hôpital Notre-Dame (Centre Hospitalier de l'Université de Montréal), Montréal, Quebéc, Canada 1Centre de Recherche du Centre Hospitalier de l'Université de Montréal (CRCHUM), Institut du Cancer de Montréal, Montréal, Quebec, Canada. Division of Urology, Université de Montreal, Montreal, Quebec, Canada Matthew R. Smith, Massachusetts General Hospital Cancer Center, Boston, MA; Fred Saad, University of Montreal Hospital Center, Montreal, Quebec, Canada; Stephane Oudard, Georges Pompidou Hospital, Paris; Karim Fizazi, Institut Gustave Roussy, University of Paris Sud, Villejuif, France; Neal Shore, Carolina Urological Research Center, Myrtle Beach, SC; Paul Sieber, Urological Associates of Lancaster, Lancaster, PA; Bertrand Tombal, Université Catholique de Louvain Cliniques Universitaires Saint Luc,... Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montréal Health Center Montréal Quebec Canada Authors' Affiliations: 1Departments of Radiation Oncology, Medical Biophysics, Medical Oncology, Laboratory Medicine and Pathology and Biostatistics, University of Toronto; 2Radiation Medicine Program, Princess Margaret Hospital, University Health Network; 3Informatics and Bio-Computing Platform, Ontario Institute for Cancer Research, Toronto, Ontario; 4Department of Cancer Genetics and Developmental Biology, British Columbia Cancer Research Centre; 5Laboratory for Advanced Genome Analysis - Vancouver Prostate Centre, Vancouver, British Columbia; 6Department of Pathology and Molecular Medicine, McMaster University, Hamilton, Ontario, Canada; 7Center for Prostate Disease Research, Department of Surgery, Uniformed Services University of the Health Sciences, Rockville, Maryland; 8Division of Urology, University of Montreal Health Center, Montreal, Quebec; 9Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario; and 10Department of Pathology and Laboratory Medicine and Oncology, Un Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada; Université de Montréal Endowed Chair in Prostate Cancer, Montreal, Quebec, Canada; Centre de recherche du Centre Hospitalier de l'Université de Montréal and Institut du cancer de Montréal, Montreal, Quebec, Canada; Department of Surgery, Université de Montréal, Montreal, Quebec, Canada 9Centre Hospitalier de l'Université de Montréal, Montreal, Quebec, Canada. Division of Urology Department of Surgery Centre Hospitalier de l’Université de Montréal Montréal QC Canada Cancer Prognostics and Health Outcomes Unit, Division of Urology University of Montréal Health Center Montréal Canada CRCUM-Université de Montréal, Hamilton, Ontario, Canada. fred.saad.chum@ssss.gouv.qc.ca Centre Hospitalier de l'Université de Montréal, Montréal, QC, Canada. Electronic address: fred.saad@umontreal.ca. Centre de Recherche du Centre Hospitalier de l'Université de Montréal, Montréal, Québec, Canada; Institut du Cancer de Montréal, Montréal, Québec, Canada; Department of Surgery, Université de Montréal, Montréal, Québec, Canada. Centre Hospitalier de l'Université de Montréal, Université de Montréal, Montréal, Québec, Canada Department of Surgery/Urology, Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada. Centre Hospitalier de l'Université de Montréal/CRCHUM, Montréal, QC, Canada. Electronic address: fred.saad@umontreal.ca. Centre de recherche du Centre Hospitalier de l'Université de Montréal Institut du cancer de Montréal Montreal Quebec Canada; Centre Hospitalier de l'Université de Montréal Center Montreal Quebec Canada 3Centre Hospitalier de l’Université de Montréal, Montreal, Quebec, Canada. From the Weston Park Hospital, Cancer Research Centre, Yorkshire Cancer Research Academic Unit of Clinical Oncology, Sheffield, United Kingdom; McMaster University, Juravinski Cancer Centre, Hamilton, Ontario; University of Waterloo, Department of Statistics and Actuarial Science, Waterloo, Ontario; Centre Hospitalier de l'Université de Montréal, Hôpital Notre-Dame, Montréal, Quebec, Canada; Milton S. Hershey Medical Center, Division of Oncology, Hershey, PA; Massachusetts General Hospital, Department of... Matthew Smith, Massachusetts General Hospital, Boston, MA; Johann De Bono, Royal Marsden Hospital, Sutton; Syed Hussain, University of Liverpool, Liverpool, United Kingdom; Cora Sternberg, San Camillo and Forlanini Hospitals, Rome; Ugo De Giorgi, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori–Istituto di Ricovero e Cura a Carattere Scientifico, Meldola; Giorgio Cruciani, Istituto Tumori Romagna, Lugo di Romagna, Italy; Sylvestre Le Moulec, Hôpital d’Instruction des Armées Val-de-Grâce;... 1Centre de recherche du Centre hospitalier de l'Université de Montréal et Institut du cancer de Montréal, Montreal, Canada.; 29Department of Surgery, Université de Montréal, Montreal, Canada. CHU de Montréal Montréal QC Canada 6University of Montreal Hospital Center, Montreal, Quebec, Canada. University of Montreal Hospital Center (F.S.), Montreal, Québec, Canada H2X 0A9 10Centre Hospitalier de l'Universite de Montreal, Hopital Notre-Dame, Department of Urologic Oncology, Montreal, Quebec Canada, Cancer Prognostics and Health Outcomes Unit Division of Urology University of Montreal Health Center Montreal Quebec Canada Division of Urology, Cancer Prognostics and Health Outcomes Unit University of Montréal Health Center Montréal Québec Canada Montréal University Health Centres, QC, Canada. University of Montreal Health Center, CHUM, Montreal, Quebec, Canada. Authors' Affiliations: 1Goodman Cancer Research Centre, 2Department of Medicine, Division of Experimental Medicine; 3Department of Biochemistry and Oncology, McGill University; 4Service d'anatomopathologie, Hôpital du Sacré-Cœur de Montréal; 5Centre de recherche du CHUM (CR-CHUM), and Institut du cancer de Montréal; 6Department of Medicine, Université de Montréal; 7Department of Surgery, CHUM, Université de Montréal, Montréal, Québec, Canada; and 8Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Authors' Affiliations: 1Goodman Cancer Research Centre, 2Department of Medicine, Division of Experimental Medicine; 3Department of Biochemistry and Oncology, McGill University; 4Service d'anatomopathologie, Hôpital du Sacré-Cœur de Montréal; 5Centre de recherche du CHUM (CR-CHUM), and Institut du cancer de Montréal; 6Department of Medicine, Université de Montréal; 7Department of Surgery, CHUM, Université de Montréal, Montréal, Québec, Canada; and 8Cold Spring Harbor Laboratory, Cold Spring Harbor, New York Cancer Prognostics and Health Outcomes Unit, Division of Urology, University of Montreal Health Center, Montreal, QC, Canada Montréal University Health Centre, Montréal, Canada. |
Incoming Links
Total number of triples: 1016.